<DOC>
	<DOCNO>NCT00044356</DOCNO>
	<brief_summary>The purpose clinical trial determine Allovectin-7速 , experimental gene-based immunotherapy , shrink melanoma tumor . The trial also examine treatment improve time disease progression .</brief_summary>
	<brief_title>Phase II Trial Allovectin-7速 Metastatic Melanoma</brief_title>
	<detailed_description>Treatment - If take part trial treat 10 week . You receive injection Allovectin-7速 needle , directly one select tumor week first six week . The injection may give doctor 's office . During four-week observation period , disease measure see treatment work . This do general physical exam scan ( X-ray scan ) . Patients show sign disease progression may offer option repeat treatment course .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>In order trial , must meet enrollment criterion . Below list enrollment criterion . You diagnose Stage III Stage IV melanoma Your cancer return prior treatment ( e.g . radiation chemotherapy ) refuse therapy standard treatment You able carry normal daily activity Your melanoma spread brain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Metastatic Melanoma</keyword>
	<keyword>Malignant Melanoma</keyword>
	<keyword>Skin Cancer</keyword>
	<keyword>Tumor</keyword>
	<keyword>Experimental Treatment</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Gene Therapy</keyword>
	<keyword>Gene Delivery</keyword>
	<keyword>Gene Transfer</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Cancer</keyword>
	<keyword>Neoplasm</keyword>
	<keyword>Lesion</keyword>
	<keyword>Metastasis</keyword>
	<keyword>Cancerous mole</keyword>
	<keyword>Melanoma vaccine</keyword>
	<keyword>Cancer research</keyword>
	<keyword>Cancer cell</keyword>
	<keyword>Allovectin-7速</keyword>
</DOC>